Swapping a Broken Heart for a New Start novel Chapter 267

Sandra Taylor’s mind was spinning.

Camila Davis… was actually cooperating this easily? Was there really something wrong with the medication?

Sensing her hesitation, Camila Davis jumped in. “What’s the matter? Scared to submit the data?” She smirked, her voice dripping with sarcasm. “Relax, both sets of numbers are identical. Even if I wanted to pull a fast one, I couldn’t! Or… is it that you’re hiding something?”

The FDA reps immediately shot Sandra sharp looks.

Sandra gritted her teeth. “Why would I have anything to hide? Fine. Send it in!”

No way, she thought, no way would Camila risk sabotaging her own research.

If this drug really was flawed, The Smith Group couldn’t bring it to market—and neither could she!

With that in mind, Sandra stopped hesitating and sent the files off to the authorities.

The FDA agents wasted no time. They compared both sets of data immediately—identical, down to the last decimal.

But Camila’s copy included a detailed breakdown, pointing out that two of the ingredient ratios didn’t meet the required standards. That’s what caused the dangerous side effects and the drug’s chemical instability.

The agents didn’t make a decision right away. They forwarded everything to their own experts for evaluation.

It only took about fifteen minutes before a reply came back.

The lead agent cleared his throat and announced, “After a thorough review by our specialists, Ms. Davis’s analysis is accurate. The Smith Group’s so-called miracle drug has dangerous interactions due to substandard ingredient ratios. What was supposed to be life-saving could actually cause serious heart damage. Effective immediately, all existing batches must be destroyed.”

“This is impossible!” Sandra blurted out.

Jordan Smith’s brow furrowed. “Could there be some mistake?”

Jordan’s face fell.

Camila knew him well enough to recognize that look. She pressed her advantage. “Well, Mr. Smith, it seems you’ve got your answer. So, shouldn’t we be calling the authorities now?

Sandra Taylor isn’t even a trained pharmacologist, yet she was leading the R&D team on a new drug. That’s a clear violation—she should be thoroughly investigated.

Frankly, I have reason to believe she was chasing profits, with no regard for patient safety.

And what’s worse, she let Mr. Reed take the drug before it was cleared, nearly killing him. That’s attempted manslaughter. Whether The Smith Group acted intentionally or not, there needs to be a full investigation.

Let’s not forget, Mr. Reed may be retired, but he’s still a pillar of the scientific community, mentoring new talent. We can’t just sweep this under the rug, not after what almost happened to him!”

---